Breaking News
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Varian Medical Q1 Profit Rises, Guides Q2 EPS Below View

RELATED NEWS
Trade VAR now with 
1/24/2013 12:13 AM ET

Varian Medical Systems Inc. (VAR: Quote) Wednesday reported higher profit for the first quarter as revenue increased 8 percent with improvements in both segments. However, earnings per share were less than what analysts had expected. The company guided second-quarter profit below Street view and raised the lower end of its full year profit outlook. The stock fell over 4 percent in after-hours trading.

Dow Wilson, CEO, said, ''The company's first quarter revenues and net earnings grew in line with our expectations for both our Oncology Systems and X-Ray Products businesses. Margins were also in line with our expectations. Excluding the restructuring charge in the quarter, our operating margin improved versus the year-ago quarter.''

Net income climbed to $95.3 million or $0.86 per share from $90.2 million or $0.79 per share in the year-ago quarter.

The latest results included a $4.1 million restructuring charge related to an enhanced retirement program.

On average, 14 analysts polled by Thomson Reuters expected the company to earn $0.87 per share for the quarter. Analysts' estimates typically exclude special items.

Gross margin dropped to 42.9 percent from 43.0 percent.

Revenues rose 8 percent to $678.4 million from $625.3 million. Analysts had a consensus revenue estimate of $676.14 million for the quarter.

Revenue from Oncology Systems increased 8 percent to $524.3 million, and X-Ray Products revenue increased 18 percent to $132.9 million. Net orders climbed to $619.2 million from $606.1 million in the prior year, as a small decline in Oncology Systems, due to weaker orders in Europe and Asia, was offset by increased orders at X-Ray Products. Looking forward to the second quarter, net earnings per share are estimated in the range of $0.98 to $1.03 with the balance of restructuring charges from the enhanced retirement program. The company expects revenues to increase 5 to 6 percent year-over-year.

Analysts currently expect the company to earn $1.04 per share on revenue of $774.26 million for the second quarter.

For fiscal year 2013, the company continues to believe that revenues could increase 8 to 9 percent. Net earnings per share for fiscal 2013 could be in the range of $4.08 to $4.16. Previously, the company expected fiscal 2013 earnings to be in the range of $4.06 to $4.16 per share.

Analysts currently expect the company to earn $4.12 per share on revenue of $3.04 billion for the fiscal year 2013.

VAR closed down 0.3 percent on Wednesday at $74.91, and fell 4.2 percent in the extended trade.

Register
To receive FREE breaking news email alerts for Varian Medical Systems and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Restaurant operator Yum! Brands Inc. said Tuesday after the markets closed that its first quarter profit rose 18% from last year, helped by strong performance of its China division. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast. After trending higher over the past several sessions, stocks saw some further upside during trading on Tuesday. A positive reaction to the latest corporate news contributed to the continued buying interest, lifting the Dow and the S&P 500 back near their record highs. In a blow to supporters of affirmative action, the Supreme Court on Tuesday upheld a voter-approved ban on using race as a factor in college admissions at Michigan's state-run universities. The court ruled 6 to 2 that the state law banning the use of racial preferences does not violate the U.S. Constitution, although the court was splintered on the reasoning for the decision.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.